ID

38111

Description

Study ID: 105036 Clinical Study ID: 105036 Study Title: A single-blind, randomized, placebo-controlled study to investigate the safety, tolerability, and potential effects on betamethasone pharmacokinetics of a co-administered infusion of GSK221149A in healthy female subjects Patient Level Data: Study Listed on ClinicalStudyDataRequest.com Clinicaltrials.gov Identifier: N/A Sponsor: GlaxoSmithKline Collaborators: N/A Phase: Phase 1 Study Recruitment Status: Completed Generic Name: betamethasone Trade Name: Retosiban Study Indication: Women's Health & Pregnancy - Other, pre-term labour

Keywords

Versions (1)
  1. 9/18/19 9/18/19 -
Copyright Holder

GlaxoSmithKline

Uploaded on

September 18, 2019

DOI

To request one please log in.

License

Creative Commons BY-NC 3.0
Model comments :

You can comment on the data model here. Via the speech bubbles at the itemgroups and items you can add comments to those specificially.

Back to model comments
Itemgroup comments for :

Item comments for :

In order to download data models you must be logged in. Please log in or register for free.

Betamethasone pharmacokinetics of a co-administered infusion of GSK221149A; 105036

English

Pharmacokinetics Blood

1 forms  
  1. StudyEvent: ODM
    1. Pharmacokinetics Blood
Dosing Date and Time
Description

Dosing Date and Time

Alias
UMLS CUI-1
C0031328
UMLS CUI-2
C0178602
UMLS CUI-3
C0011008
UMLS CUI-4
C0040223
Dosing date/time
Description

Pharmacokinetic aspects, Dosage, Date in time, Time

Data type

datetime

Alias
UMLS CUI [1,1]
C0031328
UMLS CUI [1,2]
C0178602
UMLS CUI [1,3]
C0011008
UMLS CUI [1,4]
C0040223
Predose
Description

Predose

Alias
UMLS CUI-1
C0031328
UMLS CUI-2
C0439565
Actual time
Description

Pharmacokinetic aspects, Pre-dose, Time

Data type

time

Alias
UMLS CUI [1,1]
C0031328
UMLS CUI [1,2]
C0439565
UMLS CUI [1,3]
C0040223
0,5 Hour post dose
Description

0,5 Hour post dose

Alias
UMLS CUI-1
C0031328
UMLS CUI-2
C0439568
UMLS CUI-3
C1442458
Actual time
Description

Pharmacokinetic aspects, Post-dose, 30 Minutes , Time

Data type

time

Alias
UMLS CUI [1,1]
C0031328
UMLS CUI [1,2]
C0439568
UMLS CUI [1,3]
C1442458
UMLS CUI [1,4]
C0040223
6 Hours post dose
Description

6 Hours post dose

Alias
UMLS CUI-1
C0031328
UMLS CUI-2
C0439568
UMLS CUI-3
C1292428
Actual time
Description

Pharmacokinetic aspects, Post-dose, 6 Hours, Time

Data type

time

Alias
UMLS CUI [1,1]
C0031328
UMLS CUI [1,2]
C0439568
UMLS CUI [1,3]
C1292428
UMLS CUI [1,4]
C0040223
12 Hours post dose
Description

12 Hours post dose

Alias
UMLS CUI-1
C0031328
UMLS CUI-2
C0439568
UMLS CUI-3
C1292430
Actual time
Description

Pharmacokinetic aspects, Post-dose, 12 Hours, Time

Data type

time

Alias
UMLS CUI [1,1]
C0031328
UMLS CUI [1,2]
C0439568
UMLS CUI [1,3]
C1292430
UMLS CUI [1,4]
C0040223
24 Hours post dose
Description

24 Hours post dose

Alias
UMLS CUI-1
C0031328
UMLS CUI-2
C0439568
UMLS CUI-3
C1442770
Actual time
Description

Pharmacokinetic aspects, Post-dose, 24 Hours, Time

Data type

time

Alias
UMLS CUI [1,1]
C0031328
UMLS CUI [1,2]
C0439568
UMLS CUI [1,3]
C1442770
UMLS CUI [1,4]
C0040223
Back to the top of the page

Similar models

Pharmacokinetics Blood

1 forms
  1. StudyEvent: ODM
    1. Pharmacokinetics Blood
Name
Type
Description | Question | Decode (Coded Value)
Data type
Alias
Item Group
Dosing Date and Time
C0031328 (UMLS CUI-1)
C0178602 (UMLS CUI-2)
C0011008 (UMLS CUI-3)
C0040223 (UMLS CUI-4)
Pharmacokinetic aspects, Dosage, Date in time, Time
Item
Dosing date/time
datetime
C0031328 (UMLS CUI [1,1])
C0178602 (UMLS CUI [1,2])
C0011008 (UMLS CUI [1,3])
C0040223 (UMLS CUI [1,4])
Item Group
Predose
C0031328 (UMLS CUI-1)
C0439565 (UMLS CUI-2)
Pharmacokinetic aspects, Pre-dose, Time
Item
Actual time
time
C0031328 (UMLS CUI [1,1])
C0439565 (UMLS CUI [1,2])
C0040223 (UMLS CUI [1,3])
Item Group
0,5 Hour post dose
C0031328 (UMLS CUI-1)
C0439568 (UMLS CUI-2)
C1442458 (UMLS CUI-3)
Pharmacokinetic aspects, Post-dose, 30 Minutes , Time
Item
Actual time
time
C0031328 (UMLS CUI [1,1])
C0439568 (UMLS CUI [1,2])
C1442458 (UMLS CUI [1,3])
C0040223 (UMLS CUI [1,4])
Item Group
6 Hours post dose
C0031328 (UMLS CUI-1)
C0439568 (UMLS CUI-2)
C1292428 (UMLS CUI-3)
Pharmacokinetic aspects, Post-dose, 6 Hours, Time
Item
Actual time
time
C0031328 (UMLS CUI [1,1])
C0439568 (UMLS CUI [1,2])
C1292428 (UMLS CUI [1,3])
C0040223 (UMLS CUI [1,4])
Item Group
12 Hours post dose
C0031328 (UMLS CUI-1)
C0439568 (UMLS CUI-2)
C1292430 (UMLS CUI-3)
Pharmacokinetic aspects, Post-dose, 12 Hours, Time
Item
Actual time
time
C0031328 (UMLS CUI [1,1])
C0439568 (UMLS CUI [1,2])
C1292430 (UMLS CUI [1,3])
C0040223 (UMLS CUI [1,4])
Item Group
24 Hours post dose
C0031328 (UMLS CUI-1)
C0439568 (UMLS CUI-2)
C1442770 (UMLS CUI-3)
Pharmacokinetic aspects, Post-dose, 24 Hours, Time
Item
Actual time
time
C0031328 (UMLS CUI [1,1])
C0439568 (UMLS CUI [1,2])
C1442770 (UMLS CUI [1,3])
C0040223 (UMLS CUI [1,4])
Back to the top of the page 

Contact

Please use this form for feedback, questions and suggestions for improvements.

Fields marked with * are required.

Help

Do you need help on how to use the search function? Please watch the corresponding tutorial video for more details and learn how to use the search function most efficiently.

Watch Tutorial